Total Funding
30
Total FundingDebt Financing raised
Growth Score in past quarter
pts
Heat Score 30 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
490869
Genomics develops and fabricates microarray technologies to bypass DNA purification and quantitation.
- Krishna jayaraman: Chairman & CEO
Michael Hogan: Co-Founder
About the Company
Genomics USA, Inc. develops and fabricates micro array technologies to bypass DNA purification and quantitation by allowing human leukocyte antigen (HLA) typing directly from raw blood (rehydrated) dried blood spots on Guthrie cards and from raw buccalswabs. It offers HLA Chip technology based on HLA typing for tissue transplantation and stem cell
therapeutics, as well as based on HLA analysis for vaccine development, personalized vaccine delivery, personalized treatment for autoimmune diseases, and personalized treatment of microbial infection. Genomics USA was incorporated in 2004 and is based in Inverness, Illinois.
